245 related articles for article (PubMed ID: 9886393)
1. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts.
Klavinskis LS; Barnfield C; Gao L; Parker S
J Immunol; 1999 Jan; 162(1):254-62. PubMed ID: 9886393
[TBL] [Abstract][Full Text] [Related]
2. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.
Klavinskis LS; Bergmeier LA; Gao L; Mitchell E; Ward RG; Layton G; Brookes R; Meyers NJ; Lehner T
J Immunol; 1996 Sep; 157(6):2521-7. PubMed ID: 8805653
[TBL] [Abstract][Full Text] [Related]
3. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates.
Lehner T; Bergmeier LA; Tao L; Panagiotidi C; Klavinskis LS; Hussain L; Ward RG; Meyers N; Adams SE; Gearing AJ
J Immunol; 1994 Aug; 153(4):1858-68. PubMed ID: 7519218
[TBL] [Abstract][Full Text] [Related]
4. Injection of plasmid DNA into the gastric mucosa induces mucosal and systemic immunity.
Sato Y; Saito A; Shishido H; Irisawa A; Miyata M; Obara K; Nishimaki T; Fujita T; Suzuki T; Kasukawa R
Cell Immunol; 2000 Jan; 199(1):58-63. PubMed ID: 10675276
[TBL] [Abstract][Full Text] [Related]
5. Induction of immunity against hepatitis B virus surface antigen by intranasal DNA vaccination using a cationic emulsion as a mucosal gene carrier.
Kim TW; Chung H; Kwon IC; Sung HC; Kang TH; Han HD; Jeong SY
Mol Cells; 2006 Oct; 22(2):175-81. PubMed ID: 17085969
[TBL] [Abstract][Full Text] [Related]
6. The cellular basis of immune induction at mucosal surfaces by DNA vaccination.
Barnfield C; Brew R; Tilling R; Rae A; Wheeler C; Klavinskis LS
Dev Biol (Basel); 2000; 104():159-64. PubMed ID: 11713815
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
8. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
[TBL] [Abstract][Full Text] [Related]
9. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10.
Chun S; Daheshia M; Lee S; Eo SK; Rouse BT
J Immunol; 1999 Sep; 163(5):2393-402. PubMed ID: 10452973
[TBL] [Abstract][Full Text] [Related]
10. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity.
Toka FN; Rouse BT
J Leukoc Biol; 2005 Jul; 78(1):178-86. PubMed ID: 15817700
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.
VanCott TC; Kaminski RW; Mascola JR; Kalyanaraman VS; Wassef NM; Alving CR; Ulrich JT; Lowell GH; Birx DL
J Immunol; 1998 Feb; 160(4):2000-12. PubMed ID: 9469464
[TBL] [Abstract][Full Text] [Related]
12. Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes.
Dupuy C; Buzoni-Gatel D; Touzé A; Bout D; Coursaget P
J Virol; 1999 Nov; 73(11):9063-71. PubMed ID: 10516012
[TBL] [Abstract][Full Text] [Related]
13. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
Buonaguro L; Devito C; Tornesello ML; Schröder U; Wahren B; Hinkula J; Buonaguro FM
Vaccine; 2007 Aug; 25(32):5968-77. PubMed ID: 17629365
[TBL] [Abstract][Full Text] [Related]
14. Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract.
Rosenthal KL; Gallichan WS
Semin Immunol; 1997 Oct; 9(5):303-14. PubMed ID: 9327525
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
Jiang JQ; Patrick A; Moss RB; Rosenthal KL
J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
[TBL] [Abstract][Full Text] [Related]
16. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
17. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
[TBL] [Abstract][Full Text] [Related]
19. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
Huang XG; Xu JQ; Ren L; Qiu C; Zhang N; Liu LX; Wan YM; Peng H; Shao YM
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3109-13. PubMed ID: 17313761
[TBL] [Abstract][Full Text] [Related]
20. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
